H.C. Wainwright reiterated coverage on Applied Genetic Technologies with a new price target

2/2/21 6:46:50 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

H.C. Wainwright reiterated coverage of Applied Genetic Technologies with a rating of Buy and set a new price target of $24.00 from $18.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AGTC

Date	Price Target	Rating	Analyst